Publicaciones científicas
-
Improvement of the Elevated Tryptase Criterion to Discriminate IgE- From Non-IgE-Mediated Allergic Reactions
Gastaminza G (1), Lafuente A (2), Goikoetxea MJ (1), D'Amelio CM (1), Bernad-Alonso A (1), Vega O (1), Martinez-Molina JA (2), Ferrer M (1), Nuñez-Cordoba JM (3).
(1) From the Departments of Allergology and Clinical Immunology.
(2) Anaesthesia.
(3) Research Support Service, Central Clinical Trials Unit, Clínica Universidad de Navarra, Pamplona, Spain.Anesthesia and Analgesia 16 de AGOSTO de 2019
-
Patient-reported outcomes and final overall survival results from the randomized phase 3 PENELOPE trial evaluating pertuzumab in low tumor human epidermal growth factor receptor 3 (HER3) mRNA-expressing platinum-resistant ovarian cancer
Lorusso D (#1), Hilpert F (#2,3), González Martin A (4,5), Rau J (6), Ottevanger P (7), Greimel E (8), Lück HJ (9), Selle F (10), Colombo N (11), Kroep JR (12), Mirza MR (13), Berger R (14), Pardo B (15), Grischke EM (16), Berton-Rigaud D (17), Martinez-Garcia J (18), Vergote I (19), Redondo A (20), Cardona A (21), Bastière-Truchot L (21), du Bois A (22), Kurzeder C (22,23); PENELOPE trial investigators.
(1) Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy
(2) Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) and Klinik für Gynäkologie und Geburtshilfe, Kiel, Germany (affiliation when work was performed).
(3) Mammazentrum am Krankenhaus Jerusalem, Hamburg, Germany.
(4) Grupo Español de Investigación en Cáncer de Ovario (GEICO) and MD Anderson Cancer Center Spain, Madrid, Spain (affiliation when work was performed).
(5) Clínica Universidad de Navarra, Madrid, Spain.
(6) Coordinating Center for Clinical Trials, Philipps-University of Marburg, Marburg, Germany.
(7) Dutch Gynaecological Oncology Group (DGOG) and Department of Medical Oncology, Radboud University Medical Center, Nijmegen, Netherlands.
(8) Medical University Graz, Graz, Austria.
(9) AGO and Gynäkologisch-Onkologische Praxis am Pelikanplatz, Hannover, Germany.
(10) Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), Groupe Hospitalier Diaconesses Croix Saint-Simon and Alliance Pour la Recherche en Cancérologie, Paris, France.
(11) Mario Negri Gynecologic Oncology (MaNGO) group, IEO, European Institute of Oncology IRCCS, and University of Milan-Bicocca, Milan, Italy.
(12) DGOG and Department of Medical Oncology, Leids Universitair Medisch Centrum, Leiden, Netherlands.
(13) Nordic Society of Gynaecological Oncology (NSGO) and Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
(14) AGO-Austria and University Hospital for Gynaecology and Obstetrics, Medical University of Innsbruck, Innsbruck, Austria.
(15) GEICO and Medical Oncology Department, Institut Català d'Oncologia, Hospital Duran i Reynals, Barcelona, Spain.
(16) AGO and University Hospital of Gynecology and Obstetrics, Tübingen, Germany.
(17) GINECO and Integrated Center for Oncology Nantes-Angers, Nantes, France.
(18) GEICO and Medical Oncology Service, Hospital Clínico Universitario Virgen de la Arrixaca, El Palmar, Spain.
(19) AGO and Leuven Cancer Institute, University Hospital Leuven, Leuven, Belgium.
(20) GEICO and Medical Oncology Department, Hospital Universitario La Paz-IdiPAZ, Madrid, Spain.
(21) F. Hoffmann-La Roche, Basel, Switzerland.
(22) AGO and Kliniken Essen Mitte, Essen, Germany.
(23) Department of Gynecology and Gynecological Oncology, University Hospital Basel, University of Basel, Basel, Switzerland.
#Contributed equallyInternational Journal of Gynecological Cancer 15 de AGOSTO de 2019
-
Hypoglossal nerve stimulation long-term clinical outcomes: a systematic review and meta-analysis
Costantino A (1), Rinaldi V (1), Moffa A (2), Luccarelli V 1, Bressi F (3), Cassano M (4), Casale M (1), Baptista P (5).
(1) Unit of Otolaryngology, UOS ORL TI, Campus Bio-Medico University, Rome, Italy.
(2) Unit of Otolaryngology, University of Foggia, Foggia, Italy.
(3) Department of Physical and Rehabilitation Medicine, Campus Bio-Medico University, Rome, Italy.
(4) Unit of Otolaryngology, University of Foggia, Foggia, Italy.
(5) Unit of Otolaryngology, Clínica Universidad de Navarra, Pamplona, Spain.Sleep Breath 15 de AGOSTO de 2019
-
VEMPs and Dysautonomia Assessment in Definite Cerebellar Ataxia, Neuropathy, Vestibular Areflexia Syndrome (CANVAS)
Moreno-Ajona D (1), Álvarez-Gómez L (2), Manrique-Huarte R (2), Rivas E (3), Martínez-Vila E (1), Pérez-Fernández N (4,5)
(1) Departamento de Neurología, Clínica Universidad de Navarra, Av. Pío XII 36, 31008, Pamplona, Navarra, Spain.
(2) Departamento de Otorrinolaringología, Clínica Universidad de Navarra, Av. Pío XII 36, 31008, Pamplona, Navarra, Spain.
(3) Departamento de Neurofisiología, Clínica Universidad de Navarra, Av. Pío XII 36, 31008, Pamplona, Navarra, Spain.
(4) Departamento de Otorrinolaringología, Clínica Universidad de Navarra, Av. Pío XII 36, 31008, Pamplona, Navarra, Spain.
(5) Departamento de Otorrinolaringología, Clínica Universidad de Navarra, Calle Marquesado de Sta. Marta, 1, 28027, Madrid, Spain.Cerebellum 15 de AGOSTO de 2019
-
Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma
Ricke J (1), Klumpen HJ (2), Amthauer H (3), Bargellini I (4), Bartenstein P (5), de Toni E (6), Gasbarrini A (7), Pech M (8), Peck-Radosavljevic M (9), Popovič P (10), Rosmorduc O (11), Schott E (12), Seidensticker M (13), Verslype C (14), Sangro B (15), Malfertheiner P (16).
(1) Department of Radiology, University Hospital, LMU Munich, Munich, Germany.
(2) Department of Medical Oncology, Amsterdam University Medical Centers, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
(3) Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
(4) Department of Interventional Radiology, Pisa University Hospitalvia Paradisa 2, 56100 Pisa, Italy.
(5) Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
(6) Department of Medicine II, Liver Center Munich, University Hospital, Munich, Germany.
(7) Internal Medicine, Gastroenterology and Hepatic Diseases Unit, IRCCS Fondazione Policlinico Universitario A. Gemelli, Università Cattolica del Sacro Cuore, Rome, Italy.
(8) Department of Radiology and Nuclear Medicine, University of Magdeburg, Leipziger Str.44, 39120, Magdeburg, Germany.
(9) Department of Internal Medicine and Gastroenterology, Klinikum Klagenfurt am Wörthersee, Klagenfurt, Austria.
(10) Clinical Institute of Radiology, University Medical Centre Ljubljana, Ljubljana, Slovenia.
(11) APHP, Hôpital La Pitié Salpêtrière, Service d'Hépato-Gastroentérologie, Paris, France.
(12) Department of Gastroenterology, Hepatology and Diabetology, Internal Medicine II, HELIOS Hospital Emil von Behring, Berlin, Germany.
(13) University Hospital, LMU Munich, Munich, Germany.
(14) Department of Digestive Oncology, University Hospital Leuven, Leuven, Belgium.
(15) Liver Unit, Clinica Universidad de Navarra-IDISNA and CIBEREHD, Pamplona, Spain.
(16) Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany.Journal of Hepatology 14 de AGOSTO de 2019
tal vezLE INTERESE
¿QUÉ TECNOLOGÍA UTILIZAMOS?
La Clínica es el hospital privado con mayor dotación tecnológica de España, todo en un único centro.
NUESTROS
PROFESIONALES
Los profesionales de la Clínica realizan una labor continuada de investigación y formación, siempre en beneficio del paciente.
POR QUÉ VENIR
A LA CLÍNICA
Conozca por qué somos diferentes a otros centros sanitarios. Calidad, rapidez, comodidad y resultados.
